Gold Alexander M 4

What Happened
Alexander M. Gold, a director of Mineralys Therapeutics, received equity awards on February 19, 2026: 6,200 restricted stock units (RSUs) and an award covering 8,300 option shares. Both awards were granted for no cash consideration (reported at $0.00). The RSUs represent contingent rights to receive one share per unit when they vest; the option award is a derivative award subject to a separate vesting schedule.

Key Details

• Transaction date: 2026-02-19; filing date: 2026-02-20 (appears timely).
• Awards: 6,200 RSUs (reported at $0.00) and 8,300 derivative/option shares (reported at $0.00). Total award count = 14,500 shares.
• Vesting: RSUs vest in one annual installment after the grant date (Footnote F1). The option award vests in 12 substantially equal monthly installments after the grant date (Footnote F2).
• Shares owned after transaction: not specified in the Form 4 filing.
• Transaction code: A = Award/Grant.

Context
These grants are compensation awards, not open-market purchases or sales, and are typically subject to vesting and potential forfeiture until vested. RSUs convert to common stock upon vesting; the option award vests monthly and would become exercisable per its schedule. Such awards are routine for directors and do not by themselves indicate a buy or sell market signal.